- Medical School - David Geffen School of Medicine at UCLA (2013-2017)
- Residency - UT Southwestern Medical Center (2017-2020), Internal Medicine
Andrew Sumarsono, M.D.
- Internal Medicine - General Internal Medicine
Andrew Sumarsono, M.D., grew up in California and received both his undergraduate and medical degree from the University of California, Los Angeles. He completed his internal medicine residency at UT Southwestern Medical Center.
Dr. Sumarsono brings a strong background in hospital medicine, medical education, mentorship, clinical research, and health care innovation. In addition to his clinical work, Dr. Sumarsono is deeply passionate about addressing health disparities, costs of care, and social determinants of health.
His research has been published in high-impact journals such as JAMA Internal Medicine, JAMA Cardiology, and JAMA Network Open. He is currently serving as an Editorial Fellow for the Journal of Hospital Medicine.
Dr. Sumarsono’s interests outside of medicine include his Christian faith and family, trying new restaurants, and traveling.
Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries.
Sumarsono A, Sumarsono N, Das SR, Vaduganathan M, Agrawal D, Pandey A, JAMA network open 2020 Feb 3 2 e200181
Trends in Aggregate Use and Associated Expenditures of Antihyperglycemic Therapies Among US Medicare Beneficiaries Between 2012 and 2017.
Sumarsono A, Everett BM, McGuire DK, Fonarow GC, Butler J, Pandey A, Vaduganathan M, JAMA internal medicine 2019 Sep
Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Sacubitril/Valsartan and Ivabradine in Heart Failure.
Sumarsono A, Vaduganathan M, Ajufo E, Navar AM, Fonarow GC, Das SR, Pandey A, JAMA cardiology 2019 Nov
- Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries.